臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 71-95 / 1137 (共46頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-06-27T07:02:07Z	Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors	Hsu C.-L.; Chen K.-Y.; Shih J.-Y.; Ho C.-C.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:02:06Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:02:04Z	Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy	Hwang C.-L.; CHONG-JEN YU; Shih J.-Y.; Yang P.-C.; Wu Y.-T.
臺大學術典藏	2022-06-27T07:02:00Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; CHONG-JEN YU; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:01:58Z	Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer	Liao W.-Y.; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T07:01:58Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.; CHONG-JEN YU; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:01:52Z	Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy	Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; CHONG-JEN YU; Yang J.C.H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:01:50Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	Lee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; CHONG-JEN YU; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H.
臺大學術典藏	2022-06-27T07:01:50Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; CHONG-JEN YU; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2022-06-27T07:01:45Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; CHONG-JEN YU; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:01:42Z	Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis	Hsu C.-L.; Chen J.-H.; Chen K.-Y.; Shih J.-Y.; Yang J.C.H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:01:39Z	Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan	Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; CHONG-JEN YU; Yang P.-C.; Chang G.-C.
臺大學術典藏	2022-06-27T07:01:38Z	Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion	Tsai T.-H.; Wu S.-G.; Hsieh M.-S.; CHONG-JEN YU; Yang J.C.H.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:29Z	Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer	Chen C.-Y.; Lin J.-W.; Huang J.-W.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:00:29Z	EGFR mutation and lobar location of lung adenocarcinoma	Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; CHONG-JEN YU; Yang P.-C.; Yang T.-Y.; Chang G.-C.
臺大學術典藏	2022-06-27T07:00:28Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	Liao B.-C.; Lee J.-H.; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; CHONG-JEN YU; Yang J.C.-H.
臺大學術典藏	2022-06-27T07:00:26Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:23Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:22Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; Shih J.-Y.; CHONG-JEN YU; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2022-06-27T07:00:20Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Liao B.-C.; Bai Y.-Y.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU; Yang J.
臺大學術典藏	2022-06-27T07:00:19Z	Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma	Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:17Z	Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review	Lin Y.-T.; CHONG-JEN YU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:16Z	The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition	Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:14Z	Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer	Chen C.-Y.; Chen Y.-Y.; Hsieh M.-S.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T07:00:13Z	Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit	Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU

顯示項目 71-95 / 1137 (共46頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52800594 線上人數 : 634 教育部委託研究計畫計畫執行:國立臺灣大學圖書館